Amendment0001_RFQ75N91024Q00126_Response to Questions.pdf

PDF 185 KB Posted

Attached to
AMENDMENT 0001_Procurement of one (1) Brand Name or Equal FormulaTrix Mantis v. 4 Liquid Dispenser and Associated Instrumentation
Solicitation number
75N91024Q00126
Issued by

About this file

This document is an amendment to Request for Quote (RFQ) #75N91024Q00126 issued by the National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services. The amendment provides responses to questions received regarding the RFQ for the procurement of one (1) Brand Name or Equal FormulaTrix Mantis v.4 Liquid Dispenser and associated instrumentation. The key details are:

The RFQ does not require the reagent to be kept cold prior to dispensing, nor does it require application support for designing assays. Offerors can provide a statement that their System for Award Management (SAM.gov) Representations and Certifications are accurate, or they can list any changes or exceptions as part of their quote. One firm fixed-price award is anticipated. Quotes in response to this RFQ must be submitted by 12:00PM EST on Friday, 07/05/2024.

View the file

Other files

File Type Posted
52.212-3(MAY2024)_FullText.pdf PDF
RFQ 75N91024Q00126 - SON.pdf PDF
RFQ 75N91024Q00126_ComSynopSolicitation.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

U.S. Department of Health & Human Services | National Institutes of Health

Date: 06/28/2024

Title: Procurement of One (1) Brand Name or Equal FormulaTrix Mantis v.4 Liquid Dispenser and

Associated Instrumentation

RFQ No.: 75N91024Q00126 Amendment No.: 0001

Subject: Questions Received for RFQ# 75N91024Q00126

This document is to serve as Amendment #001 of the subject Request for Quote (RFQ). The purpose of this amendment is for the National Cancer Institute (NCI) to formally respond to questions received in relation to the subject RFQ# 75N91024Q00126.

Following are the questions received in relation to the subject requirement:

Question:

Will you need to keep your reagent cold prior to dispensing?

Answer:

No

Do you need Application support for designing your assays?

Answer:

No

[Do] the [SAM.gov] Reps and Certs (R+C) documentation… need…to [be] submitted along with our [quote]?

Answer:

If there are no changes to the SAM.gov Reps and Certs (R+C) then a statement that the “Annual Representations and Certifications have been completed and are accurate in the System for Award Management (SAM.gov)” is sufficient.

As stated in the RFQ, the R+C are incorporated in the offer by reference under FAR 52.212(b)(2). The offeror can make changes or exceptions to parts of its R+C for the purpose of this RFQ. Changes or exceptions to the R+C must be expressly stated as part of the quote. Any changes or exceptions provided by the offeror do not automatically change the R+C in SAM.gov

U.S. Department of Health & Human Services | National Institutes of Health

File details come from the government source that posted it. Updated .